Conference Coverage

Desmoplastic trichoepithelioma may co-occur with BCC


 

AT ACDASM 2017

SYDNEY, AUSTRALIA – Watchful waiting may not be the safest approach for managing patients with desmoplastic trichoepithelioma, according to a speaker at the annual meeting of the Australasian College of Dermatologists, who described five cases of the benign tumor combined with basal cell carcinoma.

Dr. Tristan Blake, dermatology registrar at Royal Brisbane and Womens' Hospital, Brisbane, Australia

Dr. Tristan Blake

He and his colleagues conducted a retrospective review of 27 patients with DTE from a single dermatology clinic – which included reexamination of pathology specimens by dermatopathologists. They identified five patients with both DTE and BCC features in the same specimen.

“At this stage, there’s no way to confidently say, looking at the slides, if those cases were desmoplastic trichoepithelioma arising in basal cell carcinoma or vice versa, or if they were a single tumor with divergent differentiation, or an occlusion of two separate tumors,” he said.

Dr. Blake added that this was the first time, to his knowledge, that such a combination had been reported, and that the finding had the potential to change the way DTE is managed.

“How can you now confidently elect to leave or watch the desmoplastic trichoepithelioma patients you have, knowing that not an insignificant portion might also harbor BCC or develop BCC in the future?” he said. This dilemma is made more acute by the fact that DTEs are typically found in younger patients and on the face, he added.

Two dermatopathologists involved in the retrospective review of cases reported that histochemistry was not particularly useful in differentiating DTE from other tumors, he noted.

Patients in the study were also interviewed about their tumors and reported no symptoms; when asked how long the lesions had been there prior to diagnosis, those who could recall said the lesions had likely been present for decades.

In an interview, Dr. Blake said that the discovery of coexisting DTE and BCC was a surprise, and cast doubt on the practice of watchful waiting.

No conflicts of interest were declared.

Recommended Reading

Recalcitrant Solitary Erythematous Scaly Patch on the Foot
MDedge Dermatology
Merkel cell carcinoma most likely to recur within 2 years of diagnosis
MDedge Dermatology
Cutaneous Metastasis of a Pulmonary Carcinoid Tumor
MDedge Dermatology
Acquired Epidermodysplasia Verruciformis Occurring in a Renal Transplant Recipient
MDedge Dermatology
Tattoo artist survey finds almost half agree to tattoo skin with lesions
MDedge Dermatology
Chronic GVHD linked to fivefold increase in squamous cell skin carcinomas
MDedge Dermatology
Study links photosensitizing antihypertensives to SCC
MDedge Dermatology
Chemoprevention: Thinking outside the box
MDedge Dermatology
Skin cancer risk similar for liver and kidney transplant recipients
MDedge Dermatology
Mupirocin plus chlorhexidine halved Mohs surgical-site infections
MDedge Dermatology